Balanced news tone
News Sentiment
KLRA sentiment intelligence
Kailera Therapeutics, Inc. Common Stock news scored across direct company coverage, industry context, sector read-through, source quality, and freshness.
Price is moving more forcefully than the current news tone suggests.
84/100 classification confidence.
directly relevant articles
high-authority source matches
-10.3% over one week, -6.8% over four weeks, trend inactive, and near fair-value range.
Kailera Therapeutics, Inc. (NASDAQ:KLRA) Short Interest Up 96.0% in June
Market Reaction
Price moving ahead of tone
Price is moving more forcefully than the current news tone suggests.
Sentiment Mix
Positive, neutral, negative
Relevance
Why the article matched
Sources
Coverage mix
Event Lens
What the news is about
Sentiment Trail
Score over time
News Tape
Relevant headlines
Kailera Therapeutics, Inc. (NASDAQ:KLRA) Short Interest Up 96.0% in June
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 16 Jul 2026 22:45
- Source
- MarketBeat
Q1 Earnings Highs And Lows: Natera (NASDAQ:NTRA) Vs The Rest Of The Biotechnology Stocks
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 16 Jul 2026 18:49
- Source
- Market source
Kailera Therapeutics (NASDAQ:KLRA) Hits New 52-Week Low - What's Next?
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 16 Jul 2026 18:12
- Source
- MarketBeat
Unpacking Q1 Earnings: Incyte (NASDAQ:INCY) In The Context Of Other Biotechnology Stocks
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 13 Jul 2026 07:00
- Source
- Market source
Kailera Therapeutics (KLRA) is One of the Best IPO Stocks with Huge Upside Potential
- Tone
- Positive 66/100
- Event
- Market update
- Published
- 10 Jul 2026 07:00
- Source
- Market source
Kailera Stock: A Second-Wave Obesity Platform With More Than One Way To Win (NASDAQ:KLRA)
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 09 Jul 2026 07:00
- Source
- Seeking Alpha
Kailera Therapeutics (KLRA) officer receives 175,000 stock options at $23.30 strike
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 08 Jul 2026 20:20
- Source
- Stock Titan
Kailera weight loss pill trial results: Nausea sinks stock
- Tone
- Negative 42/100
- Event
- Earnings
- Published
- 08 Jul 2026 14:10
- Source
- Quartz
Update: Kailera Says Oral Small Molecule KAI-7535 Achieves Up to 11% Weight Loss in Phase 3 Trial; Shares Fall
- Tone
- Negative 22/100
- Event
- Market update
- Published
- 07 Jul 2026 18:49
- Source
- MT Newswires
Kailera Says Oral Small Molecule KAI-7535 Achieves Up to 11% Weight Loss in Phase 3 Trial
- Tone
- Negative 42/100
- Event
- Market update
- Published
- 07 Jul 2026 12:08
- Source
- MT Newswires
Kailera says obesity pill succeeds in late-stage trial in China
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 07 Jul 2026 11:59
- Source
- BioPharma Dive
Kailera Therapeutics Announces Positive Topline Data from Two Hengrui Pharma Phase 3 Clinical Trials of Oral Small Molecule GLP-1 Receptor Agonist HRS-7535/KAI-7535
- Tone
- Positive 58/100
- Event
- Market update
- Published
- 07 Jul 2026 11:00
- Source
- GlobeNewswire
Kailera shares tumble on high nausea rates despite weight-loss drug's success
- Tone
- Neutral 50/100
- Event
- Macro sensitivity
- Published
- 07 Jul 2026 07:00
- Source
- Reuters
Kailera posts late-stage trial data for oral GLP-1 drug (KLRA)
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 07 Jul 2026 07:00
- Source
- Seeking Alpha
Kailera's oral GLP-1 pill posted 11.1% weight loss in Phase 3
- Tone
- Negative 34/100
- Event
- Market update
- Published
- 07 Jul 2026 07:00
- Source
- Stock Titan
Tenet Healthcare Stock Jumps As Analysts Hold Buy Ratings Into Earnings
- Tone
- Positive 66/100
- Event
- Earnings
- Published
- 04 Jul 2026 07:00
- Source
- timothysykes.com
Why Tenet Healthcare (THC) Stock Is Up Today
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 02 Jul 2026 07:00
- Source
- TradingView
Kailera Therapeutics (KLRA) Stock Looks Overvalued Despite Its 20% Slump
- Tone
- Negative 34/100
- Event
- Market update
- Published
- 02 Jul 2026 07:00
- Source
- Market source
Cooper Companies Stock: Is COO Underperforming the Healthcare Sector?
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 16 Jun 2026 07:00
- Source
- Market source
Puma Biotechnology Stock Rises 19% in 3 Months: Here's Why
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 11 Jun 2026 07:00
- Source
- Market source
UNH stock jumps on Q1 earnings beat and raised guidance to $18.25+
- Tone
- Positive 84/100
- Event
- Earnings
- Published
- 26 May 2026 07:00
- Source
- eciks.org
There May Be Reason For Hope In Puma Biotechnology's (NASDAQ:PBYI) Disappointing Earnings
- Tone
- Negative 34/100
- Event
- Earnings
- Published
- 15 May 2026 07:00
- Source
- simplywall.st
Puma Biotechnology's (NASDAQ:PBYI) Conservative Accounting Might Explain Soft Earnings
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 14 May 2026 07:00
- Source
- Market source
Puma Biotechnology, Inc. (NASDAQ:PBYI) Analysts Are Pretty Bullish On The Stock After Recent Results
- Tone
- Positive 66/100
- Event
- Earnings
- Published
- 11 May 2026 07:00
- Source
- simplywall.st
Earnings Update: Here's Why Analysts Just Lifted Their Puma Biotechnology, Inc. (NASDAQ:PBYI) Price Target To US$5.00
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 11 May 2026 07:00
- Source
- Market source
Kailera Therapeutics IPO And Governance Shift Draw Investor Attention
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 02 May 2026 07:00
- Source
- simplywall.st
A Kailera Therapeutics (KLRA) Insider Scooped up an Additional 500,000 Shares for $8.0 Million
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 27 Apr 2026 07:00
- Source
- The Motley Fool
Q4 Earnings Highlights: Regeneron (NASDAQ:REGN) Vs The Rest Of The Biotechnology Stocks
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 25 Apr 2026 07:00
- Source
- Market source
Biotechnology Stocks Q3 Results: Benchmarking Natera (NASDAQ:NTRA)
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 21 Apr 2026 07:00
- Source
- Market source
Kailera Announces Closing of Initial Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional Shares
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 20 Apr 2026 07:00
- Source
- Market source